| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Development of a Sarcopenia Therapeutic Based on New-Modality Protein Degradation Technology | ||||||
| TPD | Sarcopenia | **** (Master regulator of myogenic differentiation, chromatin-binding transcription regulator) | Hit | Mitos Therapeutic Inc. | RS-2026-25502426 | ||
| 2 | Development of PROTAC-based **** degrader for promoting cartilage regeneration in osteoarthritis | ||||||
| TPD | Osteoarhtritis | Tankyrase | Hit | Seoul National University | RS-2023-00217266 | ||